Goldman Sachs initiated coverage of Healthpeak Properties (DOC) with a Neutral rating and $17 price target Channel checks and modeling point to meaningful upside in senior housing occupancy, RevPOR, and margins, though gains are likely capped longer term by vacancy, affordability, and supply, while also improving cash flow visibility for NNN structures and senior housing REIT investment opportunities, the analyst tells investors in a research note. Healpeak’s portfolio has undergone a drastic shift since 2019, most notably through the merger with Physicians Realty Trust, which closed March 1, 2024, effectively doubling the size of Healthpeak’s Outpatient Medical portfolio, the firm says.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Early notable gainers among liquid option names on January 7th
- Healthpeak Properties announces formation, planned IPO of Janus Living
- Healthpeak Properties price target lowered to $17 from $20 at Cantor Fitzgerald
- Jefferies cuts Healthpeak Properties to Hold, sees another challenging Lab year
- Healthpeak Properties downgraded to Hold from Buy at Jefferies
